Jean-Pierre Valentin

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Venues

Nature reviews. Drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery 23 (7) (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery 23 (7) (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery 23 (7) (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Francois Pognan, Mario Beilmann, Harrie C M Boonen, Andreas Czich, Gordon Dear, Philip Hewitt, Tomas Mow, Teija Oinonen, Adrian Roth, Thomas Steger-Hartmann, Jean-Pierre Valentin, Freddy Van Goethem, Richard J Weaver, Peter Newham
The evolving role of investigative toxicology in the pharmaceutical industry. Nature reviews. Drug discovery (2023)
Francois Pognan, Mario Beilmann, Harrie C M Boonen, Andreas Czich, Gordon Dear, Philip Hewitt, Tomas Mow, Teija Oinonen, Adrian Roth, Thomas Steger-Hartmann, Jean-Pierre Valentin, Freddy Van Goethem, Richard J Weaver, Peter Newham
The evolving role of investigative toxicology in the pharmaceutical industry. Nature reviews. Drug discovery (2023)

Jean-Pierre Valentin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Pierre Valentin